Related Experiment Video

Updated: Feb 22, 2026

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies
08:34

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies

Published on: February 6, 2019

21.2K

Proton-based chemoradiation for synchronous bilateral non-small-cell lung cancers: A case report

Wenyin Shi1, Romaine C Nichols1, Stella Flampouri1

  • 1Department of Radiation Oncology, University of Florida College of Medicine, Gainesville, FL, USAUniversity of Florida, Proton Therapy Institute, Jacksonville, FL, USA.

Thoracic Cancer
|September 19, 2017
PubMed
Summary

Proton-beam radiation therapy successfully treated a patient with bilateral non-small-cell lung cancers when surgery was not an option. This approach allowed for higher radiation doses and chemotherapy, while protecting surrounding healthy tissues.

Keywords:
Case reportchemotherapylung cancerproton therapyradiation therapy

More Related Videos

Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer04:04

Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer

Published on: February 12, 2017

11.1K
Dynamic Lung Tumor Tracking for Stereotactic Ablative Body Radiation Therapy08:17

Dynamic Lung Tumor Tracking for Stereotactic Ablative Body Radiation Therapy

Published on: June 7, 2015

16.3K

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
9.0K